FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W121032983> ?p ?o ?g. }

• W121032983 endingPage "ES236" @default.
• W121032983 startingPage "ES231" @default.
• W121032983 abstract "Background: Opioid misuse and abuse occurring in association with the treatment of chronic non-cancer pain are not new phenomena, but their increasing prevalence in recent years is unprecedented. Advancements in pharmaceutical technologies have provided opioid-related drugs, which lack the pure mu agonist activity characteristic of the typical opioid congeners. This absent or altered mu receptor activity imparts an opioid receptor antagonistic or partial agonistic pharmacologic action, which serves to modulate the development of opioid-induced tolerance and physical dependence and facilitate detoxification and withdrawal from opioids. Opioid antagonists and partial agonists are being used in abuse deterrent strategy regimens to prevent opioid tolerance and the development of dependence, as well as in the management of opioid detoxification and treatment of withdrawal. The specific opioid antagonists and partial agonists used in these various therapeutic modalities will be the focus of this review. Objectives: Evaluate the comparative therapeutic utility of opioid antagonists and partial agonists in preventing the development of opioid tolerance and treating opioid dependence, detoxification, and withdrawal. A primary focus is the use of opioid antagonists and partial agonists within an office-based practice. Methods: A narrative review of the current literature involving the therapeutic use of opioid antagonists and partial agonists in the management of opioid tolerance, dependence, detoxification, and withdrawal. A computerized literature search in the PubMed, EMBASE, BioMed, and Cochrane Library review databases from 2008 through 2010 was performed. This search included systematic and narrative reviews, prospective and retrospective studies, as well as cross-references from bibliographies of notable primary and review articles and abstracts from scientific meetings. US Food and Drug Administration records and pharmaceutical manufacturers’ product literature were also used in the search. Conclusion: Opioid dependency, whether it results from the misuse or abuse of prescription or street drugs, continues to be a significant public health issue. Passage of DATA 2000 and US Food and Drug Administration approval of buprenorphine and buprenorphine/ naloxone has revolutionized opioid dependence therapy. The traditional addiction medicine therapy regimen of methadone maintenance, with its inherent legal limitations and restrictions, has been challenged by an office-based dependence practice with buprenorphine serving as a prominent therapeutic tool. Key words: opioid antagonist, opioid partial agonist, tolerance, dependence, detoxification, withdrawal, hyperalgesia, buprenorphine, suboxone, naloxone, naltrexone, methylnaltrexone, nalmefene, tramadol, butorphanol, nalbupine, pentazocine." @default.
• W121032983 created "2016-06-24" @default.
• W121032983 creator A5000829731 @default.
• W121032983 creator A5050662445 @default.
• W121032983 creator A5090685779 @default.
• W121032983 date "2012-07-14" @default.
• W121032983 modified "2023-10-03" @default.
• W121032983 title "Office-Based Opioid Dependence Treatment" @default.
• W121032983 cites W119743163 @default.
• W121032983 cites W1579595666 @default.
• W121032983 cites W1923689435 @default.
• W121032983 cites W1951897616 @default.
• W121032983 cites W1964032526 @default.
• W121032983 cites W1967472403 @default.
• W121032983 cites W1978373899 @default.
• W121032983 cites W1983069196 @default.
• W121032983 cites W1990391721 @default.
• W121032983 cites W2000388826 @default.
• W121032983 cites W2014523709 @default.
• W121032983 cites W2033049441 @default.
• W121032983 cites W2040327352 @default.
• W121032983 cites W2045110369 @default.
• W121032983 cites W2049229004 @default.
• W121032983 cites W2050232084 @default.
• W121032983 cites W2052329514 @default.
• W121032983 cites W2059210248 @default.
• W121032983 cites W2059538358 @default.
• W121032983 cites W2061007797 @default.
• W121032983 cites W2064056557 @default.
• W121032983 cites W2086215337 @default.
• W121032983 cites W2092853006 @default.
• W121032983 cites W2108978934 @default.
• W121032983 cites W2115687136 @default.
• W121032983 cites W2135214206 @default.
• W121032983 cites W2142675143 @default.
• W121032983 cites W2158952112 @default.
• W121032983 cites W2161286347 @default.
• W121032983 cites W2163398769 @default.
• W121032983 cites W2167105661 @default.
• W121032983 cites W2171737529 @default.
• W121032983 cites W314340635 @default.
• W121032983 cites W2416842577 @default.
• W121032983 doi "https://doi.org/10.36076/ppj.2012/15/es231" @default.
• W121032983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22786460" @default.
• W121032983 hasPublicationYear "2012" @default.
• W121032983 type Work @default.
• W121032983 sameAs 121032983 @default.
• W121032983 citedByCount "10" @default.
• W121032983 countsByYear W1210329832012 @default.
• W121032983 countsByYear W1210329832013 @default.
• W121032983 countsByYear W1210329832014 @default.
• W121032983 countsByYear W1210329832015 @default.
• W121032983 countsByYear W1210329832017 @default.
• W121032983 countsByYear W1210329832018 @default.
• W121032983 countsByYear W1210329832019 @default.
• W121032983 crossrefType "journal-article" @default.
• W121032983 hasAuthorship W121032983A5000829731 @default.
• W121032983 hasAuthorship W121032983A5050662445 @default.
• W121032983 hasAuthorship W121032983A5090685779 @default.
• W121032983 hasConcept C118552586 @default.
• W121032983 hasConcept C126322002 @default.
• W121032983 hasConcept C142724271 @default.
• W121032983 hasConcept C170493617 @default.
• W121032983 hasConcept C177713679 @default.
• W121032983 hasConcept C204787440 @default.
• W121032983 hasConcept C2776478404 @default.
• W121032983 hasConcept C2777972943 @default.
• W121032983 hasConcept C2778938600 @default.
• W121032983 hasConcept C2779886867 @default.
• W121032983 hasConcept C2780497538 @default.
• W121032983 hasConcept C2781063702 @default.
• W121032983 hasConcept C2781118164 @default.
• W121032983 hasConcept C3020000205 @default.
• W121032983 hasConcept C58732023 @default.
• W121032983 hasConcept C71924100 @default.
• W121032983 hasConcept C95190672 @default.
• W121032983 hasConcept C98274493 @default.
• W121032983 hasConceptScore W121032983C118552586 @default.
• W121032983 hasConceptScore W121032983C126322002 @default.
• W121032983 hasConceptScore W121032983C142724271 @default.
• W121032983 hasConceptScore W121032983C170493617 @default.
• W121032983 hasConceptScore W121032983C177713679 @default.
• W121032983 hasConceptScore W121032983C204787440 @default.
• W121032983 hasConceptScore W121032983C2776478404 @default.
• W121032983 hasConceptScore W121032983C2777972943 @default.
• W121032983 hasConceptScore W121032983C2778938600 @default.
• W121032983 hasConceptScore W121032983C2779886867 @default.
• W121032983 hasConceptScore W121032983C2780497538 @default.
• W121032983 hasConceptScore W121032983C2781063702 @default.
• W121032983 hasConceptScore W121032983C2781118164 @default.
• W121032983 hasConceptScore W121032983C3020000205 @default.
• W121032983 hasConceptScore W121032983C58732023 @default.
• W121032983 hasConceptScore W121032983C71924100 @default.
• W121032983 hasConceptScore W121032983C95190672 @default.
• W121032983 hasConceptScore W121032983C98274493 @default.
• W121032983 hasIssue "3S;7" @default.
• W121032983 hasLocation W1210329831 @default.
• W121032983 hasLocation W1210329832 @default.

• next